Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Background A pilot study (NCT00316563) to determine if delta-9-tetrahydrocannabinol (THC) can improve taste and smell (chemosensory) perception as well as appetite, caloric intake, and quality of life (QOL) for cancer patients with chemosensory alterations. Patients and methods Adult advanced cancer patients, with poor appetite and chemosensory alterations, were recruited from two sites and randomized in a double-blinded manner to receive either THC (2.5 mg, Marinol(®); Solvay Pharma Inc., n = 24) or placebo oral capsules (n = 22) twice daily for 18 days. Twenty-one patients completed the trial. At baseline and posttreatment, patients completed a panel of patient-reported outcomes: Taste and Smell Survey, 3-day food record, appetite and macronutrient preference assessments, QOL questionnaire, and an interview. Results THC and placebo groups were comparable at baseline. Compared with placebo, THC-treated patients reported improved (P = 0.026) and enhanced (P Conclusions THC may be useful in the palliation of chemosensory alterations and to improve food enjoyment for cancer patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Steel, R. G. D., & Torrie, J. H. (1980) · Andalas University Repository (Andalas University) · Cited by 16,995
Principles and Procedures of Statistics: A Biometrical Approach
Steel, R. G. D., & Torrie, J. H. (1980) · Andalas University Repository (Andalas University) · Cited by 15,510
Principles and Procedures of Statistics: A Biometrical Approach.
Calinski, T., Steel, R. G. D., & Torrie, J. H. (1981) · Biometrics · doi:10.2307/2530180 · Cited by 4,337
Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991) · Journal of Palliative Care · doi:10.1177/082585979100700202 · Cited by 2,683 · cited 2×
“The 11-point Edmonton Symptom Assessment System [33] was used to assess nausea.”
MethodThe CAGE Questionnaire: Validation of a New Alcoholism Screening Instrument
MAYFIELD, D., MCLEOD, G., & HALL, P. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.10.1121 · Cited by 2,249 · cited 1×
“exclusion criteria Exclusion criteria included receiving enteral or parenteral nutrition; allergies or sensitivity to THC and/or sesame seed oil; history of substance abuse (determined by review of patients’ medical records, alcohol abuse was often also assessed by CAGE questionnaire [24]) or psychotic episodes (e.”
BackgroundDistribution of cannabinoid receptors in the central and peripheral nervous system
Mackie, K. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_10 · Cited by 744 · cited 2×
“Improved sleep may be due to the presence of CB1r in the basal forebrain [20] or related to increased relaxation noted in various populations [7, 44].”
BackgroundThe Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials
Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3439 · Cited by 644
Jatoi, A., Windschitl, H. E., Loprinzi, C. L., Sloan, J. A., Dakhil, S. R., Mailliard, J. A., Pundaleeka, S., Kardinal, C. G., Fitch, T. R., Krook, J. E., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.567 · Cited by 543 · cited 3×
“[6] reported THC to stimulate appetite in 50% of patients.”
BackgroundInfluentialDronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., Lefkowitz, L., Plasse, T. F., & Shepard, K. V. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)00117-4 · Cited by 504 · cited 2×
“THC increases appetite via endocannabinoid receptors (CB1r); appetite stimulation is documented in animals [9, 10] and in healthy human [11, 12] and acquired immunodeficiency syndrome (AIDS) populations [13, 14].”
BackgroundStrasser, F., Luftner, D., Possinger, K., Ernst, G., Ruhstaller, T., Meissner, W., Ko, Y.-D., Schnelle, M., Reif, M., & Cerny, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1847 · Cited by 413
Research works printed but not linked: 1
- Unimed. Marinol (Dronabinol) Capsules. In Solvay Pharmaceuticals, Inc., Edition 2003
Cited by
ESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
“5 mg bid) for 18 days resulted in improved chemosensory perception, better taste perception of foods, and improved pre-meal appetite compared to placebo [233].”
BackgroundSelf-citationESPEN practical guideline: Clinical Nutrition in cancer
Muscaritoli, M., Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Hütterer, E., Isenring, E., Kaasa, S., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.005 · Cited by 1,702
“5 mg bid) for 18 days resulted in improved chemosensory perception, better taste perception of foods, and improved pre-meal appetite compared to placebo [69].”
BackgroundSelf-citationESPEN practical guideline: Clinical nutrition in surgery
Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hübner, M., Klek, S., Laviano, A., Ljungqvist, O., Lobo, D. N., Martindale, R. G., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.03.031 · Cited by 1,173
Greenlee, H., DuPont‐Reyes, M. J., Balneaves, L. G., Carlson, L. E., Cohen, M. R., Deng, G., Johnson, J. A., Mumber, M., Seely, D., Zick, S. M., et al. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21397 · Cited by 768
Oral complications of cancer and cancer therapy: From cancer treatment to survivorship
Epstein, J. B., Thariat, J., Bensadoun, R., Barasch, A., Murphy, B. A., Kolnick, L., Popplewell, L., & Maghami, E. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21157 · Cited by 518
Metadata
- Authors
- Brisbois, T. D., de Kock, I. H., Watanabe, S. M., Mirhosseini, M., Lamoureux, D. C., Chasen, M., MacDonald, N., Baracos, V. E., & Wismer, W. V.
- Affiliations
- University of Alberta (CA)
- University of Ottawa (CA)
- McGill University (CA)
- Corresponding author
- Wismer, W.V.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 22
- Issue
- 9
- Pages
- 2086-2093
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2147927085
- Cited by
- 246
- References
- 45
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 22 · 2023: 25 · 2022: 32 · 2021: 29 · 2020: 17 · 2019: 18 · 2018: 17 · 2017: 14 · 2016: 16 · 2015: 8 · 2014: 9 · 2013: 5 · 2012: 6
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3004 d)
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Canadian
- Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Sensory Systems › Olfactory and Sensory Function Studies
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Keywords
- delta-9-tetrahydrocannabinol, Marinol, cancer patients, appetite, energy intake, quality of life, food enjoyment, palliative care, sleep quality, macronutrient preference
- MeSH terms
- Aged, Double-Blind Method, Female, Humans, Male, Neoplasms, Palliative Care, Pilot Projects, Placebos, Quality of Life, Dronabinol, Olfactory Perception, Taste Perception
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. https://app.cochat.ai/papers/10.1093/annonc/mdq727
- The paper
- Brisbois, T. D., de Kock, I. H., Watanabe, S. M., Mirhosseini, M., Lamoureux, D. C., Chasen, M., MacDonald, N., Baracos, V. E., & Wismer, W. V. (2011). Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Annals of Oncology. https://doi.org/10.1093/annonc/mdq727
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.